Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model.

International Journal of Pharmaceutics
Sana RubabAlam Zeb

Abstract

The present study aims to develop curcumin-loaded nanostructured lipid carriers (CUR-NLCs) and investigate their neuroprotective effects in lipopolysaccharide (LPS)-induced depression and anxiety model. Nanotemplate engineering technique was used to prepare CUR-NLCs with Compritol 888 ATO and oleic acid as solid and liquid lipid, respectively. Poloxamer 188, Tween 80 and Span 80 were used as stabilizing agents for solid-liquid lipid core. The physicochemical parameters of CUR-NLCs were determined followed by in vitro drug release and in vivo neuroprotective activity in rats. The optimized CUR-NLCs demonstrated nanometric particle size of 147.8 nm, surface charge of -32.8 mV and incorporation efficiency of 91.0%. CUR-NLCs showed initial rapid followed by a sustained drug release reaching up to 73% after 24 h. CUR-NLCs significantly elevated struggling time and decreased immobility time in forced swim and tail suspension tests. A substantial increase in time spent and number of entries into the light and open compartments was observed in light-dark box and elevated plus maze models. CUR-NLCs improved the tissue architecture and suppressed the expression of p-NF-κB, TNF-α and COX-2 in brain tissues from histological and immunohist...Continue Reading

References

Aug 15, 2002·International Journal of Pharmaceutics·R H MüllerS A Wissing
Sep 19, 2002·Journal of Psychopharmacology·Shamsah B SonawallaMaurizio Fava
Oct 23, 2002·ILAR Journal·Ralph B DellRajasekhar Ramakrishnan
Oct 23, 2002·ILAR Journal·Michael F W Festing, Douglas G Altman
Feb 26, 2003·European Journal of Pharmacology·Michel Bourin, Martine Hascoët
Jan 31, 2004·Pharmacology, Biochemistry, and Behavior·André RexHeidrun Fink
Dec 29, 2004·Journal of Drug Targeting·Paul R LockmanDavid D Allen
Dec 1, 2005·Trends in Immunology·Charles L RaisonAndrew H Miller
Mar 21, 2006·BMC Complementary and Alternative Medicine·Christopher D LaoDean E Brenner
Mar 28, 2006·International Journal of Pharmaceutics·Fu-Qiang HuSu Zeng
Mar 16, 2007·Pharmacology, Biochemistry, and Behavior·Artur H Swiergiel, Adrian J Dunn
Jun 16, 2007·Advanced Drug Delivery Reviews·Paolo BlasiCarlo Rossi
Jul 10, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Heena V LadLeonard C Schalkwyk
Nov 15, 2007·Molecular Pharmaceutics·Preetha AnandBharat B Aggarwal
Mar 4, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Indu Pal KaurVandita Kakkar
Apr 1, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nicolas AntonPatrick Saulnier
Sep 4, 2008·Psychopharmacology·Shrinivas K KulkarniMahendra Bishnoi
Jan 20, 2009·Biological Psychiatry·Andrew H MillerCharles L Raison
Jul 2, 2009·Environmental Health and Preventive Medicine·Chikako Kiyohara, Kouichi Yoshimasu
Jan 9, 2010·Journal of Biomedical Nanotechnology·Ander Estella-Hermoso de MendozaMaría J Blanco-Prieto
May 28, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Arnold B EtameJames T Rutka
Dec 17, 2011·Journal of Drug Delivery·Patrícia SeverinoEliana B Souto
Oct 11, 2012·Pharmacology, Biochemistry, and Behavior·Deidiane E RibeiroAlexandre Giusti-Paiva
Nov 20, 2013·Journal of Pharmacology & Pharmacotherapeutics·Jaykaran Charan, N D Kantharia
Aug 26, 2014·Expert Opinion on Drug Delivery·Mona H Aburahma, Shaimaa M Badr-Eldin
Oct 8, 2014·International Journal of Pharmaceutics·Petra O NnamaniClaus-Michael Lehr
Dec 17, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yousef TizabiLuli Akinfiresoye
Mar 26, 2015·AAPS PharmSciTech·Liandong HuShaocheng Wang
Sep 24, 2015·International Journal of Nanomedicine·Abdel-Rahim M El-Helw, Usama A Fahmy
Jan 7, 2016·Frontiers in Molecular Neuroscience·Ruey-Horng ShihChuen-Mao Yang
May 22, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cláudia SaraivaLiliana Bernardino
May 26, 2016·Journal of Advanced Research·Nirmal V ShahGhanshyam R Parmar
Aug 20, 2016·International Journal of Nanomedicine·Alam ZebJin-Ki Kim
Sep 17, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Omer Salman QureshiJin-Ki Kim
Jun 19, 2014·Science and Technology of Advanced Materials·Jani TuoriniemiMartin Hassellöv
Aug 29, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Christos TapeinosGianni Ciofani
Oct 19, 2017·International Journal of Nanomedicine·Fakhar Ud DinAlam Zeb
Dec 5, 2017·Colloids and Surfaces. B, Biointerfaces·Heba A FathiMahmoud El-Badry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.